Clinical Trial
Aging mammary stem cells and breast cancer prevention
To examine whether rapamycin can reduce malignant markers and aberrant mammary stem/progenitor cells (MaSCs) number in surgical specimens
To examine whether rapamycin can reduce malignant markers and aberrant mammary stem/progenitor cells (MaSCs) number in surgical specimens
Head and Neck Cancer Program
Breast Cancer Program
Adolescent and Young Adult Cancer Program
Pediatric Sarcoma Program
Eye Cancer Program
Skin Cancer Program
Lung Cancer Program
Genitourinary (GU) Cancer Program
Liver Tumor and Liver Cancer Program